Nov 04, 2025 06:31
CPRX - Catalyst Pharmaceutical Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 22.81 0.56 (2.46%) | 0.02 (0.11%) | 0.02 (0.06%) | -0.03 (-0.15%) | -0.26 (-1.16%) | 0.7 (3.06%) | 0.0 (0.0%) | -0.12 (-0.53%) |
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- 0.43
- Diluted EPS:
- 0.41
- Basic P/E:
- 54.3605
- Diluted P/E:
- 57.0122
- RSI(14) 1m:
- 48.15
- VWAP:
- 23.37
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 04, 2025 06:31
Aug 26, 2025 23:12
Mar 24, 2025 06:00
Jun 07, 2024 15:30
Jun 03, 2024 13:00
May 30, 2024 17:41
May 28, 2024 12:03
May 15, 2024 12:00
May 10, 2024 14:00